Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.

Often mistaken as piles or fissures, doctors now insist on colonoscopy to detect growth in the early stages when it is ...

Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...

Surgical intervention remains a cornerstone of colorectal cancer treatment. In recent years, robotic surgery has emerged as a promising approach, offering potential advantages over traditional open ...

While the data presented are promising, botensilimab, balstilimab, and agenT-797 are currently investigational agents and have not been approved for therapeutic use in any jurisdiction. InvestingPro ...

Colorectal cancer remains the third most common malignancy worldwide, with advanced stages presenting significant challenges for treatment. A recently published study highlights the potential of ...

Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it ...

Colorectal cancer continues to be a significant health concern in Canada ... Prevention is often more straightforward than treatment, which can be invasive and challenging. As Stein states, "it's so ...

PALO ALTO, Calif. - Guardant Health , Inc. (NASDAQ: NASDAQ:GH), a precision oncology company with a market capitalization of ...

A colorectal cancer (CRC) screening public health initiative launched in Harbin, China has attracted about 830,000 participants for registration. The project utilizes fecal DNA methylation testing ...

Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and ...